Innate Pharma S.A. (IPHA)

Innate Pharma Revenue

In the year 2023, Innate Pharma had annual revenue of $68.49M with 11.63% growth.

• Revenue (ttm): $68.49M
• Revenue Growth: +11.63%
• P/S Ratio: 2.43
• Revenue / Employee: $382,626
• Employees: 179
• Market Cap: 166.75M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	68.49M	7.13M	11.63%
Dec 31, 2022	61.36M	33.28M	118.57%
Dec 31, 2021	28.07M	-57.02M	-67.01%
Dec 31, 2020	85.09M	-10.92M	-11.37%
Dec 31, 2019	96.01M	-11.98M	-11.09%
Dec 31, 2018	107.99M	55.15M	104.37%
Dec 31, 2017	52.84M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.